Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Malar J. 2012 May 4;11:154. doi: 10.1186/1475-2875-11-154.
Genetic factors play a key role in determining resistance/susceptibility to infectious disease. Susceptibility of the human host to malaria infection has been reported to be influenced by genetic factors, which could be confounders if not taken into account in the assessment of the efficacy of interventions against malaria. This study aimed to assess the relationship between haemoglobin genotypes and malaria in children under five years in a site being characterized for future malaria vaccine trials.
The study population consisted of 452 children living in four rural villages. Hb genotype was determined at enrolment. Clinical malaria incidence was evaluated over a one-year period using combined active and passive surveillance. Prevalence of infection was evaluated via bi-annual cross-sectional surveys. At each follow-up visit, children received a brief clinical examination and thick and thin blood films were prepared for malaria diagnosis. A clinical malaria was defined as Plasmodium falciparum parasitaemia >2,500 parasites/μl and axillary temperature ≥37.5°C or reported fever over the previous 24 hours.
Frequencies of Hb genotypes were 73.2% AA; 15.0% AC; 8.2% AS; 2.2% CC; 1.1% CS and 0.2% SS. Prevalence of infection at enrolment ranged from 61.9%-54.1% among AA, AC and AS children. After one year follow-up, clinical malaria incidence (95% CI) (episodes per person-year) was 1.9 (1.7-2.0) in AA, 1.6 (1.4-2.1) in AC, and 1.7 (1.4-2.0) in AS children. AC genotype was associated with lower incidence of clinical malaria relative to AA genotype among children aged 1-2 years [rate ratio (95% CI) 0.66 (0.42-1.05)] and 2-3 years [rate ratio (95% CI) 0.37 (0.18-0.75)]; an association of opposite direction was however apparent among children aged 3-4 years. AS genotype was associated with lower incidence of clinical malaria relative to AA genotype among children aged 2-3 years [rate ratio (95% CI) 0.63 (0.40-1.01)].
In this cohort of children, AC or AS genotype was associated with lower risk of clinical malaria relative to AA genotype only among children aged one to three years. It would be advisable for clinical studies of malaria in endemic regions to consider haemoglobin gene differences as a potentially important confounder, particularly among younger children.
遗传因素在决定传染病的易感性/抗性方面起着关键作用。人类宿主对疟疾感染的易感性已被报道受到遗传因素的影响,如果在评估抗疟疾干预措施的效果时不考虑这些因素,它们可能会成为混杂因素。本研究旨在评估血红蛋白基因型与五岁以下儿童疟疾之间的关系,该研究地点正在进行未来疟疾疫苗试验的特征描述。
研究人群由居住在四个农村村庄的 452 名儿童组成。在入组时确定 Hb 基因型。在为期一年的时间内,通过主动和被动监测相结合的方式评估临床疟疾的发病率。通过每两年一次的横断面调查评估感染的流行率。在每次随访时,儿童接受了简短的临床检查,并准备了厚和薄的血片进行疟疾诊断。临床疟疾定义为疟原虫血症>2500 个寄生虫/μl 和腋温≥37.5°C 或报告过去 24 小时内发热。
Hb 基因型的频率分别为 73.2% AA;15.0% AC;8.2% AS;2.2% CC;1.1% CS 和 0.2% SS。在 AA、AC 和 AS 儿童中,入组时的感染率(61.9%-54.1%)。经过一年的随访,AA 儿童的临床疟疾发病率(95%CI)(每例患者每年的发病数)为 1.9(1.7-2.0),AC 为 1.6(1.4-2.1),AS 为 1.7(1.4-2.0)。AC 基因型与 1-2 岁儿童 AA 基因型相比,临床疟疾的发病率较低[率比(95%CI)0.66(0.42-1.05)];然而,在 2-3 岁儿童中,这种关联呈相反方向。AS 基因型与 2-3 岁儿童 AA 基因型相比,临床疟疾的发病率较低[率比(95%CI)0.63(0.40-1.01)]。
在本研究的儿童队列中,AC 或 AS 基因型与 AA 基因型相比,仅在 1-3 岁儿童中与临床疟疾的风险降低相关。在疟疾流行地区进行疟疾的临床研究时,考虑血红蛋白基因差异作为一个潜在的重要混杂因素是明智的,尤其是在年龄较小的儿童中。